| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.886 | 16.305 | 15.492 | 16.339 | 16.902 | 7.036 | 8.825 | 9.660 | 13.415 | 11.257 |
| Total Income - EUR | 20.887 | 16.328 | 15.492 | 18.488 | 16.903 | 7.036 | 8.825 | 9.660 | 13.415 | 11.257 |
| Total Expenses - EUR | 7.984 | 8.814 | 8.052 | 9.029 | 8.180 | 7.703 | 8.496 | 6.392 | 10.641 | 10.364 |
| Gross Profit/Loss - EUR | 12.903 | 7.514 | 7.440 | 9.459 | 8.724 | -667 | 329 | 3.268 | 2.774 | 894 |
| Net Profit/Loss - EUR | 12.277 | 7.025 | 6.976 | 8.904 | 8.216 | -903 | 70 | 2.984 | 2.643 | 673 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Petramed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.232 | 3.390 | 1.575 | 93 | 0 | 496 | 0 | 0 | 0 | 1.194 |
| Current Assets | 14.981 | 14.078 | 11.665 | 11.004 | 10.489 | 897 | 3.344 | 5.718 | 7.229 | 5.360 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 191 | 0 | 15 | 0 | 0 | 0 | 0 | 172 | 0 | 0 |
| Cash | 14.790 | 14.078 | 11.650 | 11.004 | 10.489 | 897 | 3.344 | 5.545 | 7.229 | 5.360 |
| Shareholders Funds | 19.444 | 8.039 | 7.972 | 9.883 | 9.182 | 46 | 114 | 3.099 | 3.570 | 1.595 |
| Social Capital | 45 | 45 | 44 | 43 | 48 | 48 | 46 | 47 | 46 | 46 |
| Debts | 769 | 9.429 | 5.267 | 1.214 | 1.307 | 1.348 | 3.229 | 2.618 | 3.659 | 4.959 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Petramed S.r.l.